Follow Us!
Patient stories, informative videos and much more on our social media accounts
It is normal to feel tired both physically and mentally after unsuccessful IVF treatments. During this period when the feeling of hopelessness intensifies, you may not want to go through the IVF process again. But remember, having had an unsuccessful attempt does not mean that you will never be able to have a baby.
For a successful IVF treatment, the infertility factors must first be correctly identified. The gender breakdown of the cause of infertility is as follows:
comes to the forefront in terms of .
comes to the forefront in terms of .
However, while both male and female factors are effective in 25% of cases, no cause can be determined in 15-20% of cases.
Whatever the reason, we maximize your chances with our success boosting techniques. There are 3 most important factors in all our success boosters producing the best results; our laboratories with advanced technologies, our team's experience in this field and special techniques that only we can apply in Turkey.
We know that our couples make an average of 3.2 attempts at different centers before having a baby at Bahçeci. A significant portion of our patients come to Bahçeci as a last resort, with really difficult cases that have not been successful with standard procedures before.
Examine the techniques we use in our patient groups with repeated failed IVF attempts.
PGT is the process of examining the chromosome number and structure of embryos in detail before they are transferred. The Smart PGT method is an advanced version of standard PGT, using a system that also includes artificial intelligence.
There are many biological, technical or patient-related variables in order to make the correct diagnosis in the PGT process. Artificial intelligence collects all these variables in a common pool and evaluates tens of thousands of embryos in terms of clinical success (healthy birth, miscarriage, pregnancy failure, etc.). Thanks to the algorithms created, the results are defined much more clearly and accurately and the most accurate embryo is determined.
We are happy and proud to be the center that brought the Embryoscope, the embryo development data tracking system, to Turkey. With the Embryoscope, your embryos are examined 24/7 in the environment closest to nature, without being removed from the environment for stress-free development, and their quality is determined accordingly. The world's most dynamic tracking system, Embryoscope, provides a significant benefit in both the growth and selection of embryos that will provide a higher pregnancy rate.
Since it is a high-cost device, embryoscope is not used in many IVF centers. As Bahçeci Health Group, we closely follow the developments in the world and implement the latest technologies in our centers simultaneously with the world's leading centers in the field. We use the embryoscope device usefully and effectively in IVF treatments as a method to increase clinical success.
This is an application that provides effective results especially for cases where pregnancy does not occur despite obtaining good quality embryos. For a healthy pregnancy, the quality of the embryo as well as the characteristics of the intrauterine membrane it will attach to are important. With the ERA (Endometrial Receptivity Assay) test, we can increase the probability of pregnancy by determining the most suitable time for transfer. With the Era test, it was possible to predict whether the uterus will accept the embryos or on which day the embryo transfer is performed, the success rate in pregnancy will increase, before the embryo is transferred to the uterus.
Post-test findings show that pregnancy success can be increased by changing the treatment program and embryo transfer date, especially in some patients. In this case, it is also possible to gain information about the reason for unsuccessful attempts in the past.
This is an application that provides effective results especially for cases where pregnancy does not occur despite obtaining good quality embryos. For a healthy pregnancy, the quality of the embryo as well as the characteristics of the intrauterine membrane it will attach to are important. With the ERA (Endometrial Receptivity Assay) test, we can increase the probability of pregnancy by determining the most suitable time for transfer. With the Era test, it was possible to predict whether the uterus will accept the embryos or on which day the embryo transfer is performed, the success rate in pregnancy will increase, before the embryo is transferred to the uterus.
Post-test findings show that pregnancy success can be increased by changing the treatment program and embryo transfer date, especially in some patients. In this case, it is also possible to gain information about the reason for unsuccessful attempts in the past.
The EMBRACE test is a test that allows the measurement of pregnancy success by genetically examining the fluid in which the embryo obtained in in vitro fertilization treatments is grown.
With the EMBRACE Test, which is applied only in Bahçeci in Turkey at the same time as the world's leading in vitro fertilization centers, the healthiest embryos are found without the need for a biopsy in determining the embryos with the highest genetic chance of pregnancy.The EMBRACE test is based on taking a sample from the fluid in which the embryo grows and genetically examining this sample using NGS technology. Since an embryo biopsy is not required for analysis, the risks that may arise from the biopsy procedure are also eliminated. When developing embryos are evaluated according to the EMBRACE test results, the embryo with the highest chance of attaching to the uterus can be determined at the first embryo transfer before embryo transfer. In this way, the need for multiple treatments can be reduced in some patients.
With the MitoScore test, which examines embryos based on mitochondria, we determine the most energetic embryo with the highest probability of attaching to the uterus, thus increasing the chance of pregnancy after transfer.
By determining the genetic heritage of embryos before transfer, signs that could lead to treatment failure, such as early miscarriage, can be picked up, thus maximizing pregnancy rates.
The CD56 test is a test that determines the ratio of natural killer cells (killer cells). Although it can be examined from blood or uterine tissue, since the tissue representation of the killer cell ratio in blood is low, the preferred approach is to perform the evaluation from tissue. The result is obtained by immunohistochemical evaluation performed by expert pathologists from a tissue sample taken from the inner layer of the uterus under anesthesia, preferably between the 21st and 24th days of menstruation after the ovulation period.
In patients with high CD56 levels, immune system balancing treatments such as intralipid injections are applied during embryo transfer preparation and at certain intervals after appropriate conditions are provided.
IMSI (Intracytoplasmic Morphologically Selected Sperm Injection) is a success-enhancing technique that allows detailed examination of sperm by enlarging them in in vitro fertilization treatments.
Classically, microscopes used for microinjection help select sperm by magnifying the sperm 400 times. In the IMSI method, a special lens and computer program are used to magnify the sperm 8,000 times. In this way, the morphology of the sperm is better evaluated.
In the IMSI method, the embryologists who use this method are specially trained and experienced in this field, as well as the features of the microscope, are of great importance. At Bahçeci, we maximize both the success in cases and our experience by offering the IMSI technique free of charge to each of our patients.
As a result of scientific studies, better embryo development, higher pregnancy rates and fewer pregnancy losses have been detected thanks to the IMSI technique.
Micro TESE is a surgical method used in male infertility cases. It allows people with no sperm in their semen (azoospermia) to have sperm extracted from their testicles and have children through in vitro fertilization.
Rarely, micro TESE can be applied to people with poor sperm quality and healthy sperm can be obtained this way.
The sORP test is an important test that can indirectly determine the genetic health of the sperm and, more importantly, indicates whether any supportive treatment may be required to increase the health of the sperm before treatment.
Sperm test (spermiogram) has been widely used for many years to detect male-related infertility problems. Although spermiogram can evaluate sperm in terms of number, mobility and deformity, it does not provide the opportunity to see possible genetic damage carried by sperm.
The sORP test allows us to predict whether there is more damage than expected in the DNA structure carried by sperm in men who want to have children.
Let us call you as soon as possible regarding the issues you want to consult.
© 2010 - 2025 All rights reserved.
